SCHEMBL1073707

SCHEMBL1073707

CCC(=O)N(SC)SC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27466457 0.77 ALDH1A1 (0.35)
SCHEMBL19705374 0.74
SCHEMBL2774770 0.72
SCHEMBL14762066 0.70 ALDH1A1 (0.43)
SCHEMBL28629077 0.67 ALDH1A1 (0.44)
SCHEMBL6965759 0.67 ALDH1A1 (0.32)
SCHEMBL11528652 0.65 ALDH1A1 (0.41)
SCHEMBL11413136 0.65 ALDH1A1 (0.41)
SCHEMBL9640 0.65
SCHEMBL21765845 0.65 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448946-A1 2-CARBOXAMIDE CYCLOAMINO UREAS USEFUL AS PI3K INHIBITORS Novartis AG (CH) 2012-05-09 EP disclosed
WO-2011000855-A1 2-CARBOXAMIDE CYCLOAMINO UREAS USEFUL AS PI3K INHIBITORS NOVARTIS AG (CH) 2011-01-06 WO disclosed
EP-0528337-B1 New thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1999-10-20 EP disclosed
US-5661159-A TREATING OR PREVENTING ALLERGY OR INFLAMMATION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-08-26 US disclosed
EP-0626956-B1 QUINOLYLBENZOFURAN DERIVATIVES AS LEUKOTRIENE ANTAGONISTS FUJISAWA PHARMACEUTICAL CO (JP) 1997-05-07 EP disclosed
US-5296495-A Antiallergens, antiinflammatory FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-03-22 US disclosed
EP-0528337-A1 New thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-02-24 EP disclosed